The findings consistently demonstrate that individuals exhibiting elevated CD40LG expression within tumor tissues exhibited significantly improved prognoses in terms of both OS (HR=0.57, P <0.0001, Figure 2A) and PFS (HR=0.46, P<0.0001, Figure 2B). The gene discussed is CD40LG; the disease is neoplasm.